Choose Your News
Loading...
KemPharm (KMPH) has filed a prospectus for an $80M mixed shelf offering. [Read More]
Diffusion Pharma (DFFN) slumps 24% after hours in response to its preliminary prospectus for a public offering of stock and warrants. Prices, volumes and t... [Read More]
In a 14-2 vote, the FDA's Antimicrobial Drugs Advisory Committee backed Shionogi's (SGIOY) cefiderocol for the treatment of complicated urinary tract infec... [Read More]
Moleculin Biotech (MBRX) resumed with Outperform rating and $2 (94% upside) price target at Oppenheimer. Shares up 4% after hours. Vertex Pharmaceuticals (... [Read More]
Diplomat Pharmacy (DPLO) has completed the sale of certain assets of Envoy Health Management, LLC to Diligent Health Solutions, LLC for an undisclosed sum. [Read More]
The first participant has completed the initial cycle of treatment in a 120-subject Phase 1b/2 clinical trial evaluating Aileron Therapeutics' ([[ALRN]] +5... [Read More]
Nektar Therapeutics ([[NKTR]] +0.3%) initiates a Phase 1 clinical trial evaluating NKTR-255 in patients with relapsed/refractory non-Hodgkin lymphoma ((NHL... [Read More]
Privately held Boehringer Ingelheim announces the start of enrollment in a Phase 2 clinical trial evaluating different doses of BI 1265162, an epithelial s... [Read More]
Nano cap Titan Pharmaceuticals ([[TTNP]] -51%) slumps on an 8x surge in volume in early trade in reaction to its public offering of 40M Units... [Read More]
Gritstone Oncology (GRTS) has filed a prospectus for a $250M mixed shelf offering. [Read More]
Drug distributors McKesson (MCK), AmerisourceBergen (ABC) and Cardinal Health (CAH) are up after hours in reaction to the news that they are in talks to... [Read More]
Rhythm Pharmaceuticals (RYTM) initiates a public offering of common stock valued up to $150M. Price, volume and terms have yet to be released. [Read More]
The FDA grants Rare Pediatric Disease designation for ProQR Therapeutics' (PRQR) sepofarsen for the treatment of Leber congenital amaurosis type 10 (LCA10) [Read More]
Principia Biopharma (PRNB) commences a $125M public offering of common stock. Price, volume and terms have yet to be announced. Update: Shares down 3% afte... [Read More]
The FDA's Antimicrobial Drugs Advisory Committee will meet tomorrow, October 16, to review and discuss Shionogi's ([[SGIOY]] +0.9%) marketing application f... [Read More]
Abeona Therapeutics ([[ABEO]] +25.3%) is up on modestly higher volume on the heels of long-term results from a Phase 1/2a clinical trial evaluating autolog... [Read More]
Nano cap Plus Therapeutics ([[PSTV]] +22.4%) jumps on more than a 5x surge in volume in apparent response to a $4.6M reimbursement payment from BARDA... [Read More]
Thinly traded Principia Biopharma ([[PRNB]] +2.8%) is up out of the gate this morning in response to positive preliminary data from a Phase 1/2 clinical... [Read More]
Health authorities in Democratic Republic of Congo will start using Johnson & Johnson's ([[JNJ]] -0.5%) Ebola vaccine next month to address the current out... [Read More]
EHealth ([[EHTH]] -4.8%) is under modest pressure on the heels of a short recommendation at Off Wall Street ((OWS)) citing concerns with certain accounting... [Read More]
Loading...
Preview